Company: INMB
Filing Date: 2025-06-30
Form Type: 424B5
Source: 0001213900-25-059298
Chunk: 33

Company: Inmune Bio, Inc.
Filing Date: 2025-06-30
Form: 424B5
Chunk 33
---
isable for U.S. dollars only. Warrants will be issued in registered form only.

Upon receipt of payment and
the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated
in the applicable prospectus supplement, we will, as soon as practicable, forward the purchased securities. If less than all of the warrants
represented by the warrant certificate are exercised, a new warrant certificate will be issued for the remaining warrants.

Prior to the exercise of any
securities warrants to purchase preferred stock or common stock, holders of the warrants will not have any of the rights of holders of
the common stock or preferred stock purchasable upon exercise, including in the case of securities warrants for the purchase of common
stock or preferred stock, the right to vote or to receive any payments of dividends on the preferred stock or common stock purchasable
upon exercise.

<div align='center'>9

DESCRIPTION OF UNITS</div>

As specified in the applicable
prospectus supplement, we may issue units consisting of shares of common stock, shares of preferred stock or warrants or any combination
of such securities.

The applicable prospectus
supplement will specify the following terms of any units in respect of which this prospectus is being delivered:

| ● | the terms of the units and of any of the common stock, preferred                                                                          
 stock and warrants comprising the units, including whether and under what circumstances the securities comprising the units may be traded 
 separately;                                                                                                                               |

| ● | a description of the terms of any unit agreement governing 
 the units; and                                             |

| ● | a description of the provisions for the payment, settlement, 
 transfer or exchange of the units.                           |

<div align='center'>PLAN OF DISTRIBUTION</div>

We may sell the securities
offered through this prospectus (i) to or through underwriters or dealers, (ii) directly to purchasers, including our affiliates, (iii)
through agents, or (iv) through a combination of any these methods. The securities may be distributed at a fixed price or prices, which
may be changed, market prices prevailing at the time of sale, prices related to the prevailing market prices, or negotiated prices. The
prospectus supplement will include the following information:

| ● | the terms of the offering; |

| ● | the names of any underwriters or agents; |

| ● | the name or names of any managing underwriter or underwriters; |

| ● | the purchase price of